TipRanks
Go Ultimate55% OFF

PharmAla Biotech Holdings, Inc. (MDXXF) Ownership - Who Owns PharmAla Biotech Holdings, Inc.?

PharmAla Biotech Holdings, Inc. (MDXXF) Ownership Overview

  • 9.59% Insiders
  • 90.41% Public Companies and Individual Investors

The ownership structure of PharmAla Biotech Holdings, Inc. (MDXXF) stock is a mix of institutional, retail, and individual investors. , 9.59% is owned by Insiders, and 90.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jul 17, 2026Fraser MacdonaldC$6,370
Jul 14, 2026Fraser MacdonaldC$30,576
May 21, 2026Lennie RyerC$5,400

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

MDXXF top shareholders
Holder# of SharesType% HoldingValue
Nicholas Kadysh8,152,778Insider7.46%986,486
William Edward Keith Avery1,000,000Insider0.92%121,000
Jodi Butts700,000Insider0.64%84,700
Perry Tsergas456,000Insider0.42%55,176
Fraser Macdonald134,062Insider0.12%16,222
Lennie Ryer36,000Insider0.03%4,356

FAQ

What percentage of PharmAla Biotech Holdings, Inc. (MDXXF) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.41% of PharmAla Biotech Holdings, Inc. (MDXXF) stock is held by retail investors.
Who owns the most shares of PharmAla Biotech Holdings, Inc. (MDXXF)?
Nicholas Kadysh owns the most shares of PharmAla Biotech Holdings, Inc. (MDXXF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.